ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 48 filers reported holding ACORDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $745,000 | +63.4% | 1,079,541 | +21.9% | 0.01% | +40.0% |
| Q3 2020 | $456,000 | +342.7% | 885,299 | +534.0% | 0.01% | +400.0% |
| Q2 2020 | $103,000 | -20.8% | 139,629 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $130,000 | -94.7% | 139,629 | -88.5% | 0.00% | -91.7% |
| Q4 2019 | $2,476,000 | -12.7% | 1,213,819 | +22.8% | 0.02% | -31.4% |
| Q3 2019 | $2,836,000 | -34.2% | 988,056 | +75.7% | 0.04% | -41.7% |
| Q2 2019 | $4,313,000 | -49.1% | 562,289 | -11.8% | 0.06% | -50.8% |
| Q1 2019 | $8,471,000 | +12.8% | 637,429 | +32.2% | 0.12% | -7.6% |
| Q4 2018 | $7,512,000 | -15.6% | 482,149 | +6.5% | 0.13% | +4.8% |
| Q3 2018 | $8,897,000 | -16.1% | 452,769 | +22.6% | 0.13% | -24.6% |
| Q2 2018 | $10,599,000 | +22.6% | 369,313 | +1.0% | 0.17% | +16.0% |
| Q1 2018 | $8,647,000 | +12.3% | 365,633 | +1.8% | 0.14% | +6.7% |
| Q4 2017 | $7,701,000 | +6.3% | 359,013 | +17.2% | 0.14% | -4.3% |
| Q3 2017 | $7,242,000 | +18.8% | 306,217 | -1.0% | 0.14% | +8.5% |
| Q2 2017 | $6,095,000 | +12.4% | 309,367 | +19.8% | 0.13% | +18.2% |
| Q1 2017 | $5,422,000 | +32.4% | 258,186 | +18.6% | 0.11% | +39.2% |
| Q4 2016 | $4,094,000 | +221.6% | 217,786 | +257.1% | 0.08% | +243.5% |
| Q3 2016 | $1,273,000 | -20.6% | 60,990 | -3.0% | 0.02% | -30.3% |
| Q2 2016 | $1,604,000 | -36.0% | 62,890 | -33.7% | 0.03% | -37.7% |
| Q1 2016 | $2,508,000 | +85.6% | 94,820 | +86.0% | 0.05% | +89.3% |
| Q3 2015 | $1,351,000 | -22.5% | 50,970 | -2.6% | 0.03% | -15.2% |
| Q2 2015 | $1,744,000 | -22.4% | 52,320 | -22.5% | 0.03% | -13.2% |
| Q1 2015 | $2,247,000 | +525.9% | 67,520 | +668.1% | 0.04% | +533.3% |
| Q4 2014 | $359,000 | +11.5% | 8,790 | -7.4% | 0.01% | +20.0% |
| Q3 2014 | $322,000 | -63.1% | 9,490 | -63.3% | 0.01% | -64.3% |
| Q2 2014 | $872,000 | – | 25,860 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |